UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) July 17, 2003
CONMED CORPORATION
(Exact name of registrant as specified in its charter)
New York 0-16093 16-0977505
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
525 French Road, Utica, New York 13502
(Address of principal executive offices) (Zip Code)
(315) 797-8375
(Registrant's telephone number, including area code)
Item 7. Financial Statements and Exhibits
(c) Exhibits
The following is furnished as an Exhibit to this report:
Exhibit No. Description of Exhibit
99.1 Press Release dated July 17, 2003, issued by
CONMED Corporation
Item 9. Regulation FD Disclosure
This information is being furnished pursuant to "Item 12. Results of Operations
and Financial Condition" of Form 8K.
On July 17, 2003, CONMED Corporation issued a press release announcing second
quarter and first half 2003 results. The press release is attached hereto as
Exhibit 99.1
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CONMED CORPORATION
By:/s/ Robert D. Shallish, Jr.
---------------------------
Vice President-Finance and
Chief Financial Officer
Date: July 18, 2003
EXHIBIT INDEX
Exhibit No. Exhibit Description
99.1 Press Release, dated July 17, 2003, issued by CONMED Corporation